Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019

Journal article

Last month, the research roundup provided you with an overview of articles looking at adverse drug reactions (Robertson, 2023). This month, three articles will be reviewed that look at the complex issues encountered when prescribing during pregnancy will be reviewed. The first article looks at polypharmacy and associated risks, the second examines the use of antidepressants and the risk of gestational diabetes and the third looks at the impact of regulatory safety notices on prescribing valproate in women with childbearing potential

Authors: Subramanian, A; Azcoaga-Lorenzo, A; Anand, A; Phillips, K; Lee, SI

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: BioMed Central
• Journal: BMC Medicine
• Volume: 21
• Issue: 1
• Pages: 21-21
• Article number: 21
• Publication date: 2023-01-16
• DOI: 10.1186/s12916-022-02722-5
• EISSN: 1741-7015
• ISSN: 1741-7015
• Language: English
• Keywords: Medicine; Pharmacology; Pregnancy; Internal medicine; Medical prescription; Overweight; Logistic regression; Obstetrics; Body mass index; Polypharmacy; Pediatrics; Retrospective cohort study